11 research outputs found
Caractérisation des tumeurs et de leur évolution en TEP/TDM au F-FDG pour le suivi thérapeutique
La Tomographie par Emission de Positons (TEP) au Fluoro-déoxyglucose marqué au Fluor 18 ( F-FDG), analogue du glucose, permet d'obtenir une image de la consommation de glucose dans l'organisme. La plupart des foyers tumoraux présentant une consommation excessive de glucose, son utilisation en oncologie permet d'améliorer la prise en charge des patients en diminuant le temps nécessaire pour évaluer l'efficacité des traitements tels que la chimiothérapie et la radiothérapie. Mon projet de recherche visait à proposer et améliorer des méthodes de quantification en TEP au F-FDG afin de caractériser au mieux l'évolution métabolique des volumes tumoraux.De nombreux facteurs biaisent la quantification en TEP. Parmi eux, l'Effet de Volume Partiel (EVP) reste difficile à corriger, notamment à cause de la faible résolution spatiale des images TEP. Afin de déterminer l'impact de la correction de l EVP sur l évaluation des réponses des tumeurs, une étude sur données simulées par Monte Carlo a tout d abord été effectuée. Cette étude a été complétée par l analyse de données TEP/TDM (Tomodensitométrie) acquises chez 40 patients atteints de cancers colorectaux métastatiques (CCM), traités par chimiothérapie à l'Institut Jules Bordet (Bruxelles). L analyse de 101 tumeurs a montré que les critères tels que le SUV, n incluant pas de correction de l'EVP, et qui reflètent alors le volume tumoral et son activité, prédisaient mieux l évolution tumorale que les critères corrigés de l EVP. Compte tenus des résultats prometteurs récents de méthodes de caractérisation de l hétérogénéité de la fixation du FDG dans les tumeurs, un second volet de notre travail a consisté à étudier l intérêt de la prise en compte de la texture dans le cadre du suivi thérapeutique. L application de l analyse de texture aux cas de CCM étudiés précédemment n a pas permis de démontrer une valeur ajoutée des indices de texture par rapport aux index quantitatifs couramment employés en clinique. Nous avons montré que cette conclusion s expliquait en partie par la non-robustesse des indices de texture vis-à-vis des paramètres impliqués dans leur mesure. Nous avons enfin cherché à évaluer une méthode d Analyse Factorielle de Séquences d Images Médicales (AFSIM), appliquée au contexte du suivi thérapeutique, pour caractériser l évolution tumorale tout au long du traitement. Cette étude a porté sur 9 séries de 4 à 6 examens TEP/TDM de patients traités par radiothérapie au Centre Hospitalier Universitaire Henri Becquerel de Rouen. Outre l information visuelle globale apportée par cette méthode, l analyse quantitative des résultats obtenus a permis de caractériser l hétérogénéité de la réponse vue par l AFSIM. L échec des index classiques, provenant entre autres de leur incapacité à distinguer les processus inflammatoires de l activité métabolique tumorale, a permis de monter la valeur ajoutée de l AFSIM par rapport aux index tels que le SUV maximal ou moyen.Positron Emission Tomography (PET) using F-FluoroDeoxyGlucose ( F-FDG), a radiolabelled analogue of the glucose, is used to get an image of the glucose consumption in the body. As most tumor masses show a high glucose consumption, PET is widely used in oncology for diagnosis and patient monitoring. In the context of patient monitoring, the motivation is to decrease the time interval needed to assess treatment (radiotherapy or chemotherapy efficieny) compared to therapeutic follow-up based only on anatomic imaging only (Computed Tomography or Magnetic Resonance Imaging). My research project aimed at proposing and improving quantitative methods in FDG-PET to better characterize tumor evolution.In PET, many factors affect the accuracy of parameters estimated from the images. Among them, Partial Volume Effect (PVE) remains difficult to correct, mainly due to the low spatial resolution of PET images. To determine the impact of PVE on treatment response evaluation, a preliminary study was performed using Monte Carlo simulated PET scans. An additional study was conducted based on the analysis of the PET/CT (Computed Tomography) data of 40 Metastatic Colorectal Cancer (MCC) patients treated with chemotherapy at the Jules Bordet Institute (Brussels, Belgium). The analysis of the 101 tumors showed that criteria such as the Standardized Uptake Value (SUV), which does not include PVE correction, were better predictors of tumors evolutions than PVE corrected criteria. This is because without PVE correction, SUV includes information on both metabolic volume and metabolic activity, which are two relevant pieces of information to characterize the tumor. A second part of our work was to study the potential of tumor texture analysis in patient monitoring, following promising results reported in the literature. Texture analysis was applied to the MMC patients data previously mentioned but did allow to a better segregation of tumors responses as compared to indices currently used in the clinics. We found that this was partly due to the lack of robustness of the textures indices.Finally, we evaluated a Factor Analysis in Medical Images Series (FAMIS) method to characterize tumor evolution during treatment. This study focused on 9 series of 4 to 6 PET/CT scans acquired all along the radiotherapy/radio-chemotherapy of patients treated at the Centre Hospitalier Universitaire Henri Becquerel (Rouen, France). In addition to the rich visual information brought by this method, a quantitative analysis of the results made it possible to characterize response heterogeneity as seen using FAMIS. In particular, FAMIS clearly demonstrated the occurrence of inflammatory processes. In addition, due to the low metabolic activity of the tumors at the end of the treatment, many conventional indices could not describe the tumor changes, while FAMIS gave a full assessment of the tumor change over time.PARIS11-SCD-Bib. électronique (914719901) / SudocSudocFranceF
Nodes of Ranvier and Paranodes in Chronic Acquired Neuropathies
Chronic acquired neuropathies of unknown origin are classified as chronic inflammatory demyelinating polyneuropathies (CIDP) and chronic idiopathic axonal polyneuropathies (CIAP). The diagnosis can be very difficult, although it has important therapeutic implications since CIDP can be improved by immunomodulating treatment. The aim of this study was to examine the possible abnormalities of nodal and paranodal regions in these two types of neuropathies. Longitudinal sections of superficial peroneal nerves were obtained from biopsy material from 12 patients with CIDP and 10 patients with CIAP and studied by immunofluorescence and in some cases electron microscopy. Electron microscopy revealed multiple alterations in the nodal and paranodal regions which predominated in Schwann cells in CIDP and in axons in CIAP. In CIDP paranodin/Caspr immunofluorescence was more widespread than in control nerves, extending along the axon in internodes where it appeared intense. Nodal channels Nav and KCNQ2 were less altered but were also detected in the internodes. In CIAP paranodes, paranodin labeling was irregular and/or decreased. To test the consequences of acquired primary Schwann cells alteration on axonal proteins, we used a mouse model based on induced deletion of the transcription factor Krox-20 gene. In the demyelinated sciatic nerves of these mice we observed alterations similar to those found in CIDP by immunofluorescence, and immunoblotting demonstrated increased levels of paranodin. Finally we examined whether the alterations in paranodin immunoreactivity could have a diagnosis value. In a sample of 16 biopsies, the study of paranodin immunofluorescence by blind evaluators led to correct diagnosis in 70±4% of the cases. This study characterizes for the first time the abnormalities of nodes of Ranvier in CIAP and CIDP, and the altered expression and distribution of nodal and paranodal proteins. Marked differences were observed between CIDP and CIAP and the alterations in paranodin immunofluorescence may be an interesting tool for their differential diagnosis
Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
Caractérisation des tumeurs et de leur évolution en TEP/TDM au ¹⁸F-FDG pour le suivi thérapeutique
Positron Emission Tomography (PET) using ¹⁸F-FluoroDeoxyGlucose (¹⁸F-FDG), a radiolabelled analogue of the glucose, is used to get an image of the glucose consumption in the body. As most tumor masses show a high glucose consumption, PET is widely used in oncology for diagnosis and patient monitoring. In the context of patient monitoring, the motivation is to decrease the time interval needed to assess treatment (radiotherapy or chemotherapy efficieny) compared to therapeutic follow-up based only on anatomic imaging only (Computed Tomography or Magnetic Resonance Imaging). My research project aimed at proposing and improving quantitative methods in FDG-PET to better characterize tumor evolution.In PET, many factors affect the accuracy of parameters estimated from the images. Among them, Partial Volume Effect (PVE) remains difficult to correct, mainly due to the low spatial resolution of PET images. To determine the impact of PVE on treatment response evaluation, a preliminary study was performed using Monte Carlo simulated PET scans. An additional study was conducted based on the analysis of the PET/CT (Computed Tomography) data of 40 Metastatic Colorectal Cancer (MCC) patients treated with chemotherapy at the Jules Bordet Institute (Brussels, Belgium). The analysis of the 101 tumors showed that criteria such as the Standardized Uptake Value (SUV), which does not include PVE correction, were better predictors of tumors evolutions than PVE corrected criteria. This is because without PVE correction, SUV includes information on both metabolic volume and metabolic activity, which are two relevant pieces of information to characterize the tumor. A second part of our work was to study the potential of tumor texture analysis in patient monitoring, following promising results reported in the literature. Texture analysis was applied to the MMC patients data previously mentioned but did allow to a better segregation of tumors responses as compared to indices currently used in the clinics. We found that this was partly due to the lack of robustness of the textures indices.Finally, we evaluated a Factor Analysis in Medical Images Series (FAMIS) method to characterize tumor evolution during treatment. This study focused on 9 series of 4 to 6 PET/CT scans acquired all along the radiotherapy/radio-chemotherapy of patients treated at the Centre Hospitalier Universitaire Henri Becquerel (Rouen, France). In addition to the rich visual information brought by this method, a quantitative analysis of the results made it possible to characterize response heterogeneity as seen using FAMIS. In particular, FAMIS clearly demonstrated the occurrence of inflammatory processes. In addition, due to the low metabolic activity of the tumors at the end of the treatment, many conventional indices could not describe the tumor changes, while FAMIS gave a full assessment of the tumor change over time.La Tomographie par Emission de Positons (TEP) au Fluoro-déoxyglucose marqué au Fluor 18 (¹⁸F-FDG), analogue du glucose, permet d'obtenir une image de la consommation de glucose dans l'organisme. La plupart des foyers tumoraux présentant une consommation excessive de glucose, son utilisation en oncologie permet d'améliorer la prise en charge des patients en diminuant le temps nécessaire pour évaluer l'efficacité des traitements tels que la chimiothérapie et la radiothérapie. Mon projet de recherche visait à proposer et améliorer des méthodes de quantification en TEP au ¹⁸F-FDG afin de caractériser au mieux l'évolution métabolique des volumes tumoraux.De nombreux facteurs biaisent la quantification en TEP. Parmi eux, l'Effet de Volume Partiel (EVP) reste difficile à corriger, notamment à cause de la faible résolution spatiale des images TEP. Afin de déterminer l'impact de la correction de l’EVP sur l’évaluation des réponses des tumeurs, une étude sur données simulées par Monte Carlo a tout d’abord été effectuée. Cette étude a été complétée par l’analyse de données TEP/TDM (Tomodensitométrie) acquises chez 40 patients atteints de cancers colorectaux métastatiques (CCM), traités par chimiothérapie à l'Institut Jules Bordet (Bruxelles). L’analyse de 101 tumeurs a montré que les critères tels que le SUV, n’incluant pas de correction de l'EVP, et qui reflètent alors le volume tumoral et son activité, prédisaient mieux l’évolution tumorale que les critères corrigés de l’EVP. Compte tenus des résultats prometteurs récents de méthodes de caractérisation de l’hétérogénéité de la fixation du FDG dans les tumeurs, un second volet de notre travail a consisté à étudier l’intérêt de la prise en compte de la texture dans le cadre du suivi thérapeutique. L’application de l’analyse de texture aux cas de CCM étudiés précédemment n’a pas permis de démontrer une valeur ajoutée des indices de texture par rapport aux index quantitatifs couramment employés en clinique. Nous avons montré que cette conclusion s’expliquait en partie par la non-robustesse des indices de texture vis-à-vis des paramètres impliqués dans leur mesure. Nous avons enfin cherché à évaluer une méthode d’Analyse Factorielle de Séquences d’Images Médicales (AFSIM), appliquée au contexte du suivi thérapeutique, pour caractériser l’évolution tumorale tout au long du traitement. Cette étude a porté sur 9 séries de 4 à 6 examens TEP/TDM de patients traités par radiothérapie au Centre Hospitalier Universitaire Henri Becquerel de Rouen. Outre l’information visuelle globale apportée par cette méthode, l’analyse quantitative des résultats obtenus a permis de caractériser l’hétérogénéité de la réponse vue par l’AFSIM. L’échec des index classiques, provenant entre autres de leur incapacité à distinguer les processus inflammatoires de l’activité métabolique tumorale, a permis de monter la valeur ajoutée de l’AFSIM par rapport aux index tels que le SUV maximal ou moyen
Characterization of the tumors and their evolutions using PET/CT for treatment following
La Tomographie par Emission de Positons (TEP) au Fluoro-déoxyglucose marqué au Fluor 18 (¹⁸F-FDG), analogue du glucose, permet d'obtenir une image de la consommation de glucose dans l'organisme. La plupart des foyers tumoraux présentant une consommation excessive de glucose, son utilisation en oncologie permet d'améliorer la prise en charge des patients en diminuant le temps nécessaire pour évaluer l'efficacité des traitements tels que la chimiothérapie et la radiothérapie. Mon projet de recherche visait à proposer et améliorer des méthodes de quantification en TEP au ¹⁸F-FDG afin de caractériser au mieux l'évolution métabolique des volumes tumoraux.De nombreux facteurs biaisent la quantification en TEP. Parmi eux, l'Effet de Volume Partiel (EVP) reste difficile à corriger, notamment à cause de la faible résolution spatiale des images TEP. Afin de déterminer l'impact de la correction de l’EVP sur l’évaluation des réponses des tumeurs, une étude sur données simulées par Monte Carlo a tout d’abord été effectuée. Cette étude a été complétée par l’analyse de données TEP/TDM (Tomodensitométrie) acquises chez 40 patients atteints de cancers colorectaux métastatiques (CCM), traités par chimiothérapie à l'Institut Jules Bordet (Bruxelles). L’analyse de 101 tumeurs a montré que les critères tels que le SUV, n’incluant pas de correction de l'EVP, et qui reflètent alors le volume tumoral et son activité, prédisaient mieux l’évolution tumorale que les critères corrigés de l’EVP. Compte tenus des résultats prometteurs récents de méthodes de caractérisation de l’hétérogénéité de la fixation du FDG dans les tumeurs, un second volet de notre travail a consisté à étudier l’intérêt de la prise en compte de la texture dans le cadre du suivi thérapeutique. L’application de l’analyse de texture aux cas de CCM étudiés précédemment n’a pas permis de démontrer une valeur ajoutée des indices de texture par rapport aux index quantitatifs couramment employés en clinique. Nous avons montré que cette conclusion s’expliquait en partie par la non-robustesse des indices de texture vis-à-vis des paramètres impliqués dans leur mesure. Nous avons enfin cherché à évaluer une méthode d’Analyse Factorielle de Séquences d’Images Médicales (AFSIM), appliquée au contexte du suivi thérapeutique, pour caractériser l’évolution tumorale tout au long du traitement. Cette étude a porté sur 9 séries de 4 à 6 examens TEP/TDM de patients traités par radiothérapie au Centre Hospitalier Universitaire Henri Becquerel de Rouen. Outre l’information visuelle globale apportée par cette méthode, l’analyse quantitative des résultats obtenus a permis de caractériser l’hétérogénéité de la réponse vue par l’AFSIM. L’échec des index classiques, provenant entre autres de leur incapacité à distinguer les processus inflammatoires de l’activité métabolique tumorale, a permis de monter la valeur ajoutée de l’AFSIM par rapport aux index tels que le SUV maximal ou moyen.Positron Emission Tomography (PET) using ¹⁸F-FluoroDeoxyGlucose (¹⁸F-FDG), a radiolabelled analogue of the glucose, is used to get an image of the glucose consumption in the body. As most tumor masses show a high glucose consumption, PET is widely used in oncology for diagnosis and patient monitoring. In the context of patient monitoring, the motivation is to decrease the time interval needed to assess treatment (radiotherapy or chemotherapy efficieny) compared to therapeutic follow-up based only on anatomic imaging only (Computed Tomography or Magnetic Resonance Imaging). My research project aimed at proposing and improving quantitative methods in FDG-PET to better characterize tumor evolution.In PET, many factors affect the accuracy of parameters estimated from the images. Among them, Partial Volume Effect (PVE) remains difficult to correct, mainly due to the low spatial resolution of PET images. To determine the impact of PVE on treatment response evaluation, a preliminary study was performed using Monte Carlo simulated PET scans. An additional study was conducted based on the analysis of the PET/CT (Computed Tomography) data of 40 Metastatic Colorectal Cancer (MCC) patients treated with chemotherapy at the Jules Bordet Institute (Brussels, Belgium). The analysis of the 101 tumors showed that criteria such as the Standardized Uptake Value (SUV), which does not include PVE correction, were better predictors of tumors evolutions than PVE corrected criteria. This is because without PVE correction, SUV includes information on both metabolic volume and metabolic activity, which are two relevant pieces of information to characterize the tumor. A second part of our work was to study the potential of tumor texture analysis in patient monitoring, following promising results reported in the literature. Texture analysis was applied to the MMC patients data previously mentioned but did allow to a better segregation of tumors responses as compared to indices currently used in the clinics. We found that this was partly due to the lack of robustness of the textures indices.Finally, we evaluated a Factor Analysis in Medical Images Series (FAMIS) method to characterize tumor evolution during treatment. This study focused on 9 series of 4 to 6 PET/CT scans acquired all along the radiotherapy/radio-chemotherapy of patients treated at the Centre Hospitalier Universitaire Henri Becquerel (Rouen, France). In addition to the rich visual information brought by this method, a quantitative analysis of the results made it possible to characterize response heterogeneity as seen using FAMIS. In particular, FAMIS clearly demonstrated the occurrence of inflammatory processes. In addition, due to the low metabolic activity of the tumors at the end of the treatment, many conventional indices could not describe the tumor changes, while FAMIS gave a full assessment of the tumor change over time
Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis
International audienceTexture indices are of growing interest for tumor characterization in (18)F-FDG PET. Yet, on the basis of results published in the literature so far, it is unclear which indices should be used, what they represent, and how they relate to conventional indices such as standardized uptake values (SUVs), metabolic volume (MV), and total lesion glycolysis (TLG). We investigated in detail 31 texture indices, 5 first-order statistics (histogram indices) derived from the gray-level histogram of the tumor region, and their relationship with SUV, MV, and TLG in 3 different tumor types
Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
International audienceTo compare the performance of eight metabolic indices for the early assessment of tumour response in patients with metastatic colorectal cancer (mCRC) treated with chemotherapy
Parametric imagin for assessing tumor response follow-up with PET/CT during radiotherapy in patients with non-small cell lung cancer.
International audienc
Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy
International audienceWe sought to determine whether metabolic volume-based measurements on FDG PET/CT scans could provide additional information for predicting outcome in patients with stage III non-small-cell lung cancer (NSCLC) treated with induction chemotherapy
Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings
International audienceAbstract We previously showed that the injected activity could be reduced to 1 MBq/kg without significantly degrading image quality for the exploration of neurocognitive disorders in 18F-FDG-PET/MRI. We now hypothesized that injected activity could be reduced ten-fold. We simulated a 18F-FDG-PET/MRI ultra-low-dose protocol (0.2 MBq/Kg, PET ULD ) and compared it to our reference protocol (2 MBq/Kg, PET STD ) in 50 patients with cognitive impairment. We tested the reproducibility between PET ULD and PET STD using SUVratios measurements. We also assessed the impact of PET ULD for between-group comparisons and for visual analysis performed by three physicians. The intra-operator agreement between visual assessment of PET STD and PET ULD in patients with severe anomalies was substantial to almost perfect (kappa > 0.79). For patients with normal metabolism or moderate hypometabolism however, it was only moderate to substantial (kappa > 0.53). SUV ratios were strongly reproducible (SUVratio difference ± SD = 0.09 ± 0.08). Between-group comparisons yielded very similar results using either PET ULD or PET STD . 18F-FDG activity may be reduced to 0.2 MBq/Kg without compromising quantitative measurements. The visual interpretation was reproducible between ultra-low-dose and standard protocol for patients with severe hypometabolism, but less so for those with moderate hypometabolism. These results suggest that a low-dose protocol (1 MBq/Kg) should be preferred in the context of neurodegenerative disease diagnosis